PROK's FDA alignment news is the real rocket fuel here! 🚀 Despite the recent dip, the RSI is flirting with oversold territory, and volume spikes show big moves are still happening. This feels like a classic "buy the rumor, sell the news" pullback. With a key catalyst path confirmed, I'm calling this a BUY on weakness. #BiotechBounce

"Boom! PROK just pulled a 515% moonshot on clinical trial hype 🚀—this isn’t just a pump, it’s a full-blown rocket launch. RSI at 89? Overbought like a Black Friday sale, but that volume (328M shares!) screams FOMO. Chart’s a wild rollercoaster—classic penny stock chaos. News is hot, but the analyst cold feet say caution. If you’ve got nerves of steel, ride the wave (BUY), but pack a parachute. #PennyStockFever"